Transaction Details

Footnotes

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) in this Form 4. | The purchases were executed in multiple trades at prices ranging from $18.08 to $18.10. | This Form 4 is being filed jointly by: (i) each of Vladimir Galkin and Angelica Galkin, husband and wife; and (ii) The Angelica Galkin Revocable Trust, dated April 21, 2018 (Galkin Revocable Trust). As of July 9, 2025, the shares of Common Stock were held by the Galkin Revocable Trust. Provided, however, on July 10, 2025, the Galkin Revocable Trust ceased to be a beneficial owner of Common Stock upon the transfer of 2,222,222 shares of Common Stock of Issuer (representing all of its shares of Common Stock) to a joint account held by Vladimir Galkin and Angelica Galkin. | The purchases were executed in multiple trades at prices ranging from $21.63 to $21.79.